MHRA: Detailed Description of the Pharmacovigilance System for Parallel Imported Products
30.09.2009
There are a small number of instances where a parallel importing company is required to take on responsibility for pharmacovigilance. Examples of such instances include: when the UK reference product licence has been cancelled, when there is no ‘common origin’ between the UK and imported products (standard and complex parallel import applications).
The source of the news: http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON057401
SciencePharma
